Marta I. Lomnytska

Corrigendum to "SUROVA Study: Global Real-World Treatment Strategies And Mortality Risk Prediction In Advanced Ovarian Cancer" [International Journal of Gynecological Cancer 36 (2026) 102688].

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 30, 2026

Early death and early relapse in advanced ovarian cancer: distinct clinical phenotypes in the International SUROVA cohort.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 19, 2026

SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 12, 2025

Splenectomy as an indicator for ovarian cancer spread and complete cytoreduction.

Journal: Gynecologic oncology

Published: February 28, 2025

Barriers to healthcare access and continuity of care among Ukrainian war refugees in Europe: findings from the RefuHealthAccess study.

Journal: Frontiers in public health

Published: October 23, 2024

Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer.

Journal: Cancers

Published: March 04, 2022

Peritoneal cancer index predicts severe complications after ovarian cancer surgery.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: February 10, 2021

The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer.

Journal: Annals of surgical oncology

Published: January 25, 2020

Super-resolution microscopy can identify specific protein distribution patterns in platelets incubated with cancer cells.

Journal: Nanoscale

Published: May 16, 2019

Corrigendum to "SUROVA Study: Global Real-World Treatment Strategies And Mortality Risk Prediction In Advanced Ovarian Cancer" [International Journal of Gynecological Cancer 36 (2026) 102688].

Corrigendum to "SUROVA Study: Global Real-World Treatment Strategies And Mortality Risk Prediction In Advanced Ovarian Cancer" [International Journal of Gynecological Cancer 36 (2026) 102688].

Early death and early relapse in advanced ovarian cancer: distinct clinical phenotypes in the International SUROVA cohort.

Early death and early relapse in advanced ovarian cancer: distinct clinical phenotypes in the International SUROVA cohort.

SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer.

SUROVA study: global real-world treatment strategies and mortality risk prediction in advanced ovarian cancer.

Splenectomy as an indicator for ovarian cancer spread and complete cytoreduction.

Splenectomy as an indicator for ovarian cancer spread and complete cytoreduction.

Barriers to healthcare access and continuity of care among Ukrainian war refugees in Europe: findings from the RefuHealthAccess study.

Barriers to healthcare access and continuity of care among Ukrainian war refugees in Europe: findings from the RefuHealthAccess study.

Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer.

Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer.

Peritoneal cancer index predicts severe complications after ovarian cancer surgery.

Peritoneal cancer index predicts severe complications after ovarian cancer surgery.

The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer.

The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer.

Super-resolution microscopy can identify specific protein distribution patterns in platelets incubated with cancer cells.

Super-resolution microscopy can identify specific protein distribution patterns in platelets incubated with cancer cells.

Platelet protein biomarker panel for ovarian cancer diagnosis.

Platelet protein biomarker panel for ovarian cancer diagnosis.

The protein kinase SIK downregulates the polarity protein Par3.

The protein kinase SIK downregulates the polarity protein Par3.

Impact of genomic stability on protein expression in endometrioid endometrial cancer.

Impact of genomic stability on protein expression in endometrioid endometrial cancer.